Page last updated: 2024-10-26

eicosapentaenoic acid ethyl ester and Renal Insufficiency, Chronic

eicosapentaenoic acid ethyl ester has been researched along with Renal Insufficiency, Chronic in 1 studies

Renal Insufficiency, Chronic: Conditions in which the KIDNEYS perform below the normal level for more than three months. Chronic kidney insufficiency is classified by five stages according to the decline in GLOMERULAR FILTRATION RATE and the degree of kidney damage (as measured by the level of PROTEINURIA). The most severe form is the end-stage renal disease (CHRONIC KIDNEY FAILURE). (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Szczuko, M1
Kaczkan, M1
Drozd, A1
Maciejewska, D1
Palma, J1
Owczarzak, A1
Marczuk, N1
Rutkowski, P1
Małgorzewicz, S1

Other Studies

1 other study available for eicosapentaenoic acid ethyl ester and Renal Insufficiency, Chronic

ArticleYear
Comparison of Fatty Acid Profiles in a Group of Female Patients with Chronic Kidney Diseases (CKD) and Metabolic Syndrome (MetS)⁻Similar Trends of Changes, Different Pathophysiology.
    International journal of molecular sciences, 2019, Apr-06, Volume: 20, Issue:7

    Topics: Arachidonic Acid; Chromatography, Gas; Docosahexaenoic Acids; Eicosapentaenoic Acid; Fatty Acids; Fa

2019